AJANTPHARM — Ajanta Pharma Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹276.20bn
- IN₹271.71bn
- IN₹37.43bn
- 99
- 13
- 97
- 85
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 5,143 | 6,640 | 9,002 | 9,095 | 7,453 |
Depreciation | |||||
Non-Cash Items | -30.4 | -249 | -8.2 | -332 | 5 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2,085 | -2,780 | -4,391 | -4,395 | -848 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 3,748 | 4,568 | 5,763 | 5,620 | 7,918 |
Capital Expenditures | -3,430 | -2,394 | -1,716 | -1,488 | -1,745 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 1,202 | 150 | -1,108 | 747 | -3,851 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2,228 | -2,244 | -2,824 | -741 | -5,596 |
Financing Cash Flow Items | -25.2 | -96.5 | -407 | -759 | -34.4 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1,475 | -1,286 | -3,183 | -4,600 | -1,079 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 45.2 | 1,037 | -244 | 279 | 1,243 |